Biblio

Found 56 results

Author Keyword [ Title

Filters: Keyword is Genetic Predisposition to Disease [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Ridge PG, Mukherjee S, Crane PK, Kauwe JSK. 2013. Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.

Karch CM, Cruchaga C, Goate AM. 2014. Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.

Thambisetty M, An Y, Tanaka T. 2013. Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.

Karch CM, Ezerskiy LA, Bertelsen S, Goate AM. 2016. Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.

Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R. 2008. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.. Arch Neurol. 65(11):1518-26.

van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al.. 2004. Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.

Reynolds CA, Hong M-G, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Grönberg H et al.. 2010. Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.. Hum Mol Genet. 19(10):2068-78.

Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al.. 2017. Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.

Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al.. 2010. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.

B

Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al.. 2012. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.

C

Sonnega A, Faul JD, Ofstedal MBeth, Langa KM, Phillips JWR, Weir DR. 2014. Cohort Profile: the Health and Retirement Study (HRS).. Int J Epidemiol. 43(2):576-85.

Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al.. 2017. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JSingh, Moskvina V et al.. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.

Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al.. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.

Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA et al.. 2004. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.

Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, Griffith P, Obisesan TO, Shatz R, Borenstein A et al.. 2011. A comprehensive genetic association study of Alzheimer disease in African Americans.. Arch Neurol. 68(12):1569-79.

Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. 2005. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.. Am J Med Genet B Neuropsychiatr Genet. 139B(1):51-3.

D

Sims R, Williams J. 2016. Defining the Genetic Architecture of Alzheimer's Disease: Where Next.. Neurodegener Dis. 16(1-2):6-11.

Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS et al.. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.. Nature. 429(6987):75-9.

E

Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al.. 2014. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L et al.. 2005. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.. Hum Mol Genet. 14(3):447-60.

Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W et al.. 2014. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.. PLoS Genet. 10(3):e1004211.

Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, Sutti S, Sherva R, Kauwe JS, Naj AC, Beecham GW et al.. 2016. The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.. Neurobiol Aging. 41:115-121.

F

Lee JH, Mayeux R, Mayo D, Mo J, Santana V, Williamson J, Flaquer A, Ciappa A, Rondon H, Estevez P et al.. 2004. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.. Mol Psychiatry. 9(11):1042-51.

Fallin MDaniele, Szymanski M, Wang R, Gherman A, Bassett SS, Avramopoulos D. 2010. Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.. Neurogenetics. 11(3):335-48.